(Q44324752)

2 December 2017

title

The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate (English)

1 reference

2 December 2017

1 reference

N Lahat

1

1 reference

2 December 2017

B Alexander

series ordinal

2

1 reference

2 December 2017

D R Levin

series ordinal

3

1 reference

2 December 2017

B Moskovitz

series ordinal

4

1 reference

2 December 2017

publication date

1 January 1989

1 reference

Cancer Immunology, Immunotherapy

2 December 2017

published in

1 reference

2 December 2017

volume

28

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

208-212

1 reference

Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas

2 December 2017

cites work

1 reference

12 December 2020

Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo

1 reference

12 December 2020

T cell growth factor: parameters of production and a quantitative microassay for activity

1 reference

12 December 2020

Suppressor cells in immunodepressed bladder and prostate cancer patients

1 reference

12 December 2020

In vitro effect of cimetidine on human cell-mediated cytotoxicity. I. Inhibition of natural killer cell activity

1 reference

12 December 2020

Interleukin 2 dependence of human natural killer (NK) cell activity

1 reference

12 December 2020

The present status of radical prostatectomy for stages A and B prostatic cancer

1 reference

12 December 2020

Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF)

1 reference

12 December 2020

Metastatic malignant melanoma: regression induced by combined treatment with interferon [HuIFN-alpha(Le)] and cimetidine

1 reference

12 December 2020

Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon

1 reference

12 December 2020

Suppressor cell function in solid tumor cancer patients

1 reference

12 December 2020

Adherent suppressor cells in the blood of patients with bladder cancer

1 reference

12 December 2020

Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease

1 reference

12 December 2020

Interferon and prostaglandins: effects on human natural and lectin-induced cytotoxicity

1 reference

12 December 2020

Relationship of arachidonic acid metabolism to indomethacin-sensitive immunoregulatory function and lymphocyte PGE sensitivity in peripheral blood mononuclear cells of disseminated solid tumor cancer patients

1 reference

12 December 2020

Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease

1 reference

12 December 2020

Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients

1 reference

12 December 2020

In vivo reduction of NK activity with anti-NK 1 serum: direct evaluation of NK cells in tumor clearance

1 reference

12 December 2020

The measurement of leukocyte subsets in the peripheral blood of cancer patients with solid tumors using monoclonal antibody reagents

1 reference

12 December 2020

Systemic and in situ natural killer and suppressor cell activities in mice bearing progressively growing murine sarcoma-virus-induced tumors

1 reference

12 December 2020

Direct evidence that natural killer cells in nonimmune spleen cell populations prevent tumor growth in vivo

1 reference

12 December 2020

Comparison of the tumor inhibiting effects of three histamine H2-receptor antagonists

1 reference

12 December 2020

Heterogeneity of natural killer cells

1 reference

12 December 2020

Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors

1 reference

12 December 2020

Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients

1 reference

12 December 2020

Successful tumour immunotherapy with cimetidine in mice

1 reference

12 December 2020

Indomethacin-induced, monocyte-dependent restoration of local graft-versus-host reaction among cells from cancer patients

1 reference

12 December 2020

Cimetidine enhances interferon induced augmentation of NK cell activity and suppresses interferon production

1 reference

12 December 2020

Interleukin 2 enhances natural killing of normal lymphocytes

1 reference

12 December 2020

Inhibition of suppressor T lymphocytes (Ts) by cimetidine.

1 reference

12 December 2020

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity

1 reference

12 December 2020

In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats

1 reference

12 December 2020

The modulation of human natural killer cell activity by prostaglandins

1 reference

12 December 2020

Indomethacin-mediated enhancement of lymphocyte response to mitogens in healthy subjects and lung cancer patients

1 reference

12 December 2020

Natural cytotoxicity and antibody-dependent cytotoxicity in solid tumor cancer patients: regulation by adherent cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00204990

1 reference

release_mcbw7ox4ibdadfalfbdhrqekim

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mcbw7ox4ibdadfalfbdhrqekim

24 November 2022

mapped directly with Wikidata item

1 reference